ARWR
Arrowhead Pharmaceuticals, Inc.
$18.28
Earnings Summary
Revenue | $0Mn |
Net Profits | $-170.79Mn |
Net Profit Margins | -Inf% |
Highlights
Arrowhead Pharmaceuticals, Inc.’s revenue fell -100% since last year same period to $0Mn in the Q2 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated NaN% jump in its revenue since last 3-months.
Arrowhead Pharmaceuticals, Inc.’s net profit fell -65.91% since last year same period to $-170.79Mn in the Q2 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated -36.31% fall in its net profits since last 3-months.
Arrowhead Pharmaceuticals, Inc.’s net profit margin fell -Inf% since last year same period to -Inf% in the Q2 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Arrowhead Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.55 |
EPS Estimate Current Year | -0.55 |
Highlights
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.55 - a -243.75% fall from last quarter’s estimates.
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.55.
Key Ratios
Key ratios of the Arrowhead Pharmaceuticals, Inc. post its Q2 2024 earnings
Earning Per Share (EPS) | -1.38 |
Highlights
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) fell -43.75% since last year same period to -1.38 in the Q2 2024. This indicates that the Arrowhead Pharmaceuticals, Inc. has generated -43.75% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.16 | -1.02 | -537.5% |
2024-08-08 | -0.55 | -1.38 | -150.91% |
₹0 US Stocks a/c Opening Fee